Cilostazol preconditioning alleviates cyclophosphamide-induced cardiotoxicity in male rats: Mechanistic insights into SIRT1 signaling pathway
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 266, 118822
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- RETRACTED: Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathwayBiomedicine & Pharmacotherapy, 2017
- SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injuryFree Radical Biology and Medicine, 2013
- Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disordersCellular Signalling, 2013
- Resveratrol protects cardiomyocytes from oxidative stress through SIRT1 and mitochondrial biogenesis signaling pathwaysBiochemical and Biophysical Research Communications, 2013
- SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-κB ActivityPLOS ONE, 2012
- SIRT1 modulates MAPK pathways in ischemic–reperfused cardiomyocytesCellular and Molecular Life Sciences, 2012
- Safety and efficacy of cilostazol in the management of intermittent claudicationVascular Health and Risk Management, 2008
- Cytoprotective role of DL-α-Lipoic acid in cyclophosphamide induced myocardial toxicityMolecular and Cellular Biochemistry, 2005
- Negative Control of p53 by Sir2α Promotes Cell Survival under StressCell, 2001
- Cardiotoxicity Associated With High-Dose Cyclophosphamide TherapyArchives of internal medicine (1960), 1981